This inventor holds 7 USPTO granted patents and 2 published patent applications and 6 EPO patents. Top assignees: Chemo Research, S.l., Laboratorios Leon Farma Sa, Chiesi Farmaceutici S.p.a.. Active years: 1992-2020.
Company Filing History:
2 out of 13 
2 out of 21 
1 out of 341 
Years Active: 1992-2020
Title: Celestino Ronchi: Innovator in Pharmaceutical and Cosmetic Compositions
Introduction
Celestino Ronchi is a notable inventor based in Milan, Italy. He has made significant contributions to the fields of pharmaceuticals and cosmetics, holding a total of 7 patents. His work focuses on developing innovative compositions that enhance the delivery and effectiveness of active ingredients.
Latest Patents
One of Ronchi's latest patents involves pharmaceutical or cosmetic compositions that comprise a polymer and an absorption promoter for the controlled release of active ingredients. This invention discloses a composition or medical device for topical use that includes a cosmetically or pharmaceutically active substance, a polyvinylcaprolactam/polyvinyl acetate/polyethylene glycol copolymer, and a phospholipid. Additionally, he has developed core sheath drug delivery devices, which consist of a core made of polyurethane and a sheath made of ethylene vinyl acetate copolymer. This device is designed to contain one or more active pharmaceutical ingredients dissolved or dispersed in the core and/or sheath, along with a process for its preparation.
Career Highlights
Throughout his career, Ronchi has worked with various companies, including Chemo Research, S.L. and Laboratorios Leon Farma S.A. His experience in these organizations has allowed him to refine his expertise in drug delivery systems and formulations.
Collaborations
Ronchi has collaborated with notable professionals in his field, including Gonzalo Hernández Herrero and Giancarlo Ceschel. These partnerships have contributed to the advancement of his innovative projects and patents.
Conclusion
Celestino Ronchi's contributions to pharmaceutical and cosmetic innovations demonstrate his commitment to enhancing the effectiveness of active ingredients through advanced delivery systems. His work continues to impact the industry positively.